These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 12716443)

  • 1. Drugs in development: bisphosphonates and metalloproteinase inhibitors.
    Catterall JB; Cawston TE
    Arthritis Res Ther; 2003; 5(1):12-24. PubMed ID: 12716443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bisphosphonates and combined treatments osteoporosis].
    Rizzoli R; Ferrari S
    Rev Med Suisse; 2005 Oct; 1(35):2266, 2269-71. PubMed ID: 16268449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloproteinase inhibitors: new opportunities for the treatment of rheumatoid arthritis and osteoarthritis.
    Shaw T; Nixon JS; Bottomley KM
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1469-78. PubMed ID: 11060752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update.
    Fleisch H
    Horm Metab Res; 1997 Mar; 29(3):145-50. PubMed ID: 9137986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tetracyclines on bone metabolism.
    Vernillo AT; Rifkin BR
    Adv Dent Res; 1998 Nov; 12(2):56-62. PubMed ID: 9972123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphenyl sulfonylamino methyl bisphosphonic acids as inhibitors of matrix metalloproteinases and bone resorption.
    Rubino MT; Agamennone M; Campestre C; Campiglia P; Cremasco V; Faccio R; Laghezza A; Loiodice F; Maggi D; Panza E; Rossello A; Tortorella P
    ChemMedChem; 2011 Jul; 6(7):1258-68. PubMed ID: 21714093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates in osteoporosis: recent clinical experience.
    McClung MR
    Expert Opin Pharmacother; 2000 Jan; 1(2):225-38. PubMed ID: 11249544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP inhibition and downregulation by bisphosphonates.
    Teronen O; Heikkilä P; Konttinen YT; Laitinen M; Salo T; Hanemaaijer R; Teronen A; Maisi P; Sorsa T
    Ann N Y Acad Sci; 1999 Jun; 878():453-65. PubMed ID: 10415748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New bisphosphonates in osteoporosis.
    Fleisch H
    Osteoporos Int; 1993; 3 Suppl 2():S15-22. PubMed ID: 8481594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of bisphosphonates in arthritis.
    Le Goff B; Heymann D
    Expert Rev Clin Pharmacol; 2011 Sep; 4(5):633-41. PubMed ID: 22220307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of bisphosphonates in the prevention and treatment of osteoporosis.
    Papapoulos SE
    Am J Med; 1993 Nov; 95(5A):48S-52S. PubMed ID: 8256796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diphosphonates--pharmacology and clinical use].
    Aaseth J; Syversen U; Førre O
    Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1064-6. PubMed ID: 9531831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase inhibitors: applications in oncology.
    Yip D; Ahmad A; Karapetis CS; Hawkins CA; Harper PG
    Invest New Drugs; 1999; 17(4):387-99. PubMed ID: 10759405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials with bisphosphonates.
    Lombardi A; Santora AC
    Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bisphosphonates in osteoporosis therapy. Standards and perspectives].
    Reinsdorf S; Habermann B; Hochmuth K; Kurth AA
    Orthopade; 2007 Feb; 36(2):110-7. PubMed ID: 17252258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases.
    Johnson LL; Dyer R; Hupe DJ
    Curr Opin Chem Biol; 1998 Aug; 2(4):466-71. PubMed ID: 9736919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective use of bisphosphonates in osteoporosis.
    Fleisch H
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1397-8. PubMed ID: 8501141
    [No Abstract]   [Full Text] [Related]  

  • 20. Denosumab and bisphosphonates: different mechanisms of action and effects.
    Baron R; Ferrari S; Russell RG
    Bone; 2011 Apr; 48(4):677-92. PubMed ID: 21145999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.